EXPE
62
-2
PCG
81
-2
F
40
-6
VNO
51
2
PEG
41
-2
PRGO
39
-3
BF.B
50
3
CTAS
61
2
WDC
50
-3
KSS
36
-3
GT
28
-4
M
25
-5
SPG
56
-5
HCA
51
-6
ALLE
23
-7
PH
62
-5
BSX
67
-2
EQT
34
-5
TEL
68
-6
ECL
64
-16
EXPE
62
-2
PCG
81
-2
F
40
-6
VNO
51
2
PEG
41
-2
PRGO
39
-3
BF.B
50
3
CTAS
61
2
WDC
50
-3
KSS
36
-3
GT
28
-4
M
25
-5
SPG
56
-5
HCA
51
-6
ALLE
23
-7
PH
62
-5
BSX
67
-2
EQT
34
-5
TEL
68
-6
ECL
64
-16
Financhill
Back

Range Oncology Therapeutics ETF Vs. Virtus LifeSci Biotech Clinical Trls ETF Industry Stock Comparison

Sell
41

CNCR
Range Oncology Therapeutics ETF

Last Price:
14.50
Seasonality Move:
2.37%
Sell
49

BBC
Virtus LifeSci Biotech Clinical Trls ETF

Last Price:
28.00
Seasonality Move:
3.56%
Sell
41
Range Oncology Therapeutics ETF (CNCR) is a Sell

Is Range Oncology Therapeutics ETF a Buy, Sell or Hold?

  • The current Range Oncology Therapeutics ETF [CNCR] share price is $14.27. The Score for CNCR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
49
Virtus LifeSci Biotech Clinical Trls ETF (BBC) is a Sell

Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?

  • The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $26.85. The Score for BBC is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • BBC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CNCR Stock Price Chart

What is Range Oncology Therapeutics ETF's stock price today?

  • The Range Oncology Therapeutics ETF share price today is $14.27
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.

BBC Stock Price Chart

What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?

  • The Virtus LifeSci Biotech Clinical Trls ETF share price today is $26.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBC is experiencing buying pressure, which is a positive indicator for future bullish movement.

CNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 41.74 Sell
Chaikin Money Flow: -1822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.44 - 15.04) Sell
Bollinger Bands (100): (14.47 - 16.39) Sell

BBC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.08 Buy
Relative Strength Index (14 RSI): 47.85 Sell
Chaikin Money Flow: 1257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.55 - 27.63) Sell
Bollinger Bands (100): (25.99 - 29.09) Sell

CNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.63 Sell
20-day SMA: 14.65 Sell
50-day SMA: 14.91 Sell
200-day SMA: 13.45 Buy
8-day EMA: 14.56 Sell
20-day EMA: 14.68 Sell
50-day EMA: 14.92 Sell
200-day EMA: 14.25 Buy

BBC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 27.36 Sell
20-day SMA: 27.03 Sell
50-day SMA: 26.86 Sell
200-day SMA: 24.13 Buy
8-day EMA: 27.25 Sell
20-day EMA: 27.13 Sell
50-day EMA: 27.1 Sell
200-day EMA: 25.57 Buy

Range Oncology Therapeutics ETF Earnings Growth & CNCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Range Oncology Therapeutics ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):